Edition:
United States

People: Pfizer Inc (PFE)

PFE on New York Consolidated

31.19USD
7 Dec 2016
Change (% chg)

$-0.37 (-1.17%)
Prev Close
$31.56
Open
$31.33
Day's High
$31.33
Day's Low
$30.60
Volume
44,053,675
Avg. Vol
23,588,491
52-wk High
$37.39
52-wk Low
$28.25

Dolsten, Mikael 

Dr. Mikael Dolsten, M.D., Ph.D., is President - Worldwide Research and Development of the Company. He was Senior Vice President; President of Worldwide Research and Development from May 2010 until December 2010. Senior Vice President; President of Pfizer BioTherapeutics Research & Development Group from October 2009 until May 2010. He was Senior Vice President of Wyeth and President, Wyeth Research from June 2008 until October 2009. He was a Private Equity Partner at Orbimed Advisors, LLC from January 2008 until June 2008. Director of Karyopharm Therapeutics Inc.

Basic Compensation

Total Annual Compensation, USD 3,057,500
Restricted Stock Awards, USD 603,492
Long-Term Incentive Plans, USD --
All Other, USD 2,396,870
Fiscal Year Total, USD 6,057,870

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ian Read

17,988,000

Frank D'Amelio

6,670,170

Albert Bourla

--

Mikael Dolsten

6,057,870

John Young

5,918,920

Rady Johnson

--
As Of  30 Dec 2015